8-K: Reinsurance Group of America Reports Strong First Quarter Results, Driven by Favorable Biometric Claims Experience

Reinsurance Group of America (RGA) announces a strong first quarter with net income of $4.27 per diluted share and adjusted operating income of $5.66 per diluted share, driven by favorable biometric claims experience.

Summary

• Reinsurance Group of America (RGA) reported first quarter net income available to RGA shareholders of $286 million, or $4.27 per diluted share.
• This compares to $210 million, or $3.16 per diluted share, in the prior-year quarter.
• Adjusted operating income for the first quarter totaled $378 million, or $5.66 per diluted share, compared with $401 million, or $6.02 per diluted share, the year before.
• The company deployed $418 million into in-force block transactions during the quarter.
• Consolidated net premiums totaled $4.0 billion, a decrease of 25% over the first quarter of 2024, with an adverse net foreign currency effect of $60 million.
• After adjusting for a single premium pension risk transfer transaction, consolidated net premiums increased 13%.
• First quarter investment income increased 13%, excluding spread-based businesses, primarily due to higher average invested assets.
• The effective tax rate for the quarter was 22.2% on pre-tax income and 21.9% on adjusted operating income before taxes, below the expected range of 23% to 24% due to U.S. tax benefits.
• The board of directors declared a regular quarterly dividend of $0.89, payable May 27, 2025, to shareholders of record as of May 13, 2025.
• RGA has approximately $4.0 trillion of life reinsurance in force and assets of $128.2 billion as of March 31, 2025.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with strong first quarter results, favorable biometric claims experience, and a robust balance sheet. While there are some negative aspects, the overall tone is optimistic and confident.

Positives

• Favorable biometric claims experience across all segments contributed positively to the results.
• The company deployed $418 million into in-force block transactions.
• The balance sheet is robust with estimated excess capital of $1.9 billion and deployable capital of $1.3 billion.
• Book value per share increased to $172.53 from $143.92 in the prior year.
• Investment income increased 13%, excluding spread-based businesses.
• The effective tax rate was lower than expected due to U.S. tax benefits.

Negatives

• Consolidated net premiums decreased by 25% compared to the first quarter of 2024.
• Adjusted operating income decreased from $401 million to $378 million year-over-year.
• Net foreign currency fluctuations had an unfavorable effect of $0.09 per diluted share.
• Average investment yield decreased to 4.64% from 4.70% in the prior-year period.

Risks

• Adverse changes in mortality, morbidity, lapsation, or claims experience could negatively impact future results.
• Inadequate risk analysis and underwriting could lead to losses.
• Adverse capital and credit market conditions could affect liquidity and access to capital.
• Fluctuations in U.S. or foreign currency exchange rates, interest rates, or securities and real estate markets could impact financial performance.
• The threat of natural disasters, catastrophes, terrorist attacks, pandemics, epidemics, or other major public health issues could disrupt business operations.
• The company's ability to complete the Reinsurance Transaction on a timely basis or at all, including as a result of the failure to satisfy any closing conditions, including those related to regulatory approvals, or, if the Reinsurance Transaction is completed, to achieve the expected benefits of the Reinsurance Transaction

Future Outlook

The company sees an attractive pipeline for both organic new business and in-force transactions, with a good balance between each, despite macro uncertainties.

Management Comments

• Tony Cheng, President and Chief Executive Officer, commented, 'Our first quarter was very good, and we are off to a strong start for the year.'
• Management believes that the capital deployed was into high quality transactions that they expect to deliver attractive returns over time.

Industry Context

RGA is a leading global provider of life and health reinsurance and financial solutions, competing with other major reinsurers in a global market. The results reflect the ongoing trends in the reinsurance industry, including the importance of managing biometric risks and deploying capital into in-force transactions.

Comparison to Industry Standards

• It is difficult to make a direct comparison to industry standards without specific competitor data.
• However, RGA's focus on adjusted operating income and ROE is consistent with industry practices.
• Companies like Swiss Re, Munich Re, and Hannover Re are key competitors in the global reinsurance market.
• RGA's reported ROE of 7.5% and adjusted operating ROE of 13.4% can be benchmarked against these peers when their results are released.
• The deployment of $418 million into in-force block transactions is a common strategy in the reinsurance industry to grow and optimize capital.

Stakeholder Impact

• Shareholders will benefit from the increased net income and the regular quarterly dividend.
• Employees can be positively impacted by the company's strong performance and growth prospects.
• Customers will continue to receive reinsurance services from a financially stable and capable provider.
• Suppliers and creditors can have confidence in the company's ability to meet its obligations.

Next Steps

• The company will hold a conference call on May 2, 2025, to discuss the financial and operating results.
• The transaction with subsidiaries of Equitable Holdings, Inc. is expected to close in mid-2025.
• The next quarterly dividend of $0.89 per share will be paid on May 27, 2025.

Key Dates

Keywords

reinsurance, financial results, earnings, operating income, net income, premiums, dividends, capital, biometric claims, RGA